Publications
Ebadi M, Fan X, Schoch G, Gooley T, Rashidi A, Smith SD, Shadman M, Holmberg L, Ujjani C, Poh C, Raghunathan V, Ali N, Vo PT, Manjappa S, Menon M, Di M, Lynch R, Ho C, Till BG, Ermoian R, Gopal AK, Tseng YD. Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Haematopoietic Stem Cell Transplantation for Relapsed/Refractory Large B-cell Lymphoma. Clinical oncology (Royal College of Radiologists (Great Britain)). 2025. PMID: 41172559
Finn RS, Rugo HS, Cortes J, Loibl S, Foley G, Gauthier E, Wang Y, Kim S, Anders L, Slamon DJ. A Decade After Approval of the First CDK4/6 Inhibitor: A Look Back at Palbociclib's Journey from Discovery to Approval and What's Next in CDK Inhibition in Breast Cancer. Targeted oncology. 2025. PMID: 41087648
Gelmon K, Villarreal-Garza C, Aubel D, S Rugo H, Maués J, Travado L, Van Meerveld M, C W Chidebe R, Patel B, Attfield G, Lewis A, Cardoso F. Improving the quality of life of people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (goal 3). Breast (Edinburgh, Scotland). 2025. PMID: 41298008
Kiely B, Travado L, Smith AL, Timeus IA, Kim SB, Haidinger R, N M Nanre N, Rugo H, Attfield G, Lewis A, Cardoso F. Increasing awareness of and referral to support services in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 7). Breast (Edinburgh, Scotland). 2025. PMID: 41298009
Shah NJ, Shinde R, Bhattacharya R, LeMasters T, Ning N, Schmier J, Tan M, Vickery D, Perini R, Motzer RJ. Postimmunotherapy and Vascular Endothelial Growth Factor Inhibitor Landscape in Advanced Renal Cell Carcinoma: Treatment Patterns, Costs, and Outcomes. JCO oncology practice. 2025. PMID: 41082704
Oseran AS, Aggarwal R, Wadhera RK. Cardiovascular Risk Factor Management in Medicare Advantage and Traditional Medicare. Circulation. Cardiovascular quality and outcomes. 2025. PMID: 41064875
Manabe T, Bergo HC, Li Q, Wang TS, Severson P, Miller N, Lee C, Donderici EY, Zhang N, Wu W, Chou YT, Kerr DL, Allegakoen P, Grandinetti KB, Soroceanu L, Pelham RJ, Martin ES, Murphy EA, Khanna V, Neal JW, Chen CT, Kato S, Williams R, Bivona TG. Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies. Research square. 2025. PMID: 41282105
Bardossy ES, Bergmann L, Henrion-Lacritick A, Nigg J, Correy GJ, Ashworth A, Fraser JS, Saleh MC. Macrodomain ADP-ribose binding but not ADP-ribosylhydrolase activity is critical for chikungunya virus infection of Aedes mosquitoes. bioRxiv : the preprint server for biology. 2025. PMID: 41279946
Keenan BP, Qiao G, Kunda N, Kone L, Guldberg SM, Todeschini L, Kumar P, Pollini T, Hernandez S, Qin J, Fong L, Spitzer MH, Prabhakar BS, Maker AV. Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastases. Science advances. 2025. PMID: 41061056
Burstein HJ, Curigliano G, Gnant M, Loibl S, Regan MM, Loi S, Denkert C, Poortmans P, Cameron D, Thurlimann B, Weber WP, Panelists of the St. Gallen International Breast Cancer Consensus 2025. Electronic address: https://, Panelists of the St. Gallen International Breast Cancer Consensus 2025. Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2025. PMID: 41072918
Modi S, Jacot W, Iwata H, Park YH, Vidal Losada M, Li W, Tsurutani J, Ueno NT, Zaman K, Prat A, Papazisis K, Rugo HS, Yamashita T, Harbeck N, Im SA, De Laurentiis M, Pierga JY, Wang X, Gombos A, Tokunaga E, Orbegoso Aguilar C, Yung L, Xiao F, Cheng Y, Cameron D. Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial. Nature medicine. 2025. PMID: 41062831
Bidard FC, Gessain G, Bachelot T, Frechin L, Vincent-Salomon A, Drubay D, Lemonnier J, Walter T, Penault-Llorca F, Martin AL, Gaudin C, Bichat A, Sassi F, Berlemont S, Chavez-MacGregor M, Rugo HS, Badoual C, Pistilli B, Ribeiro J, Di Meglio A, Lacroix-Triki M, Luis IV, Lerousseau M, André F. Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025. PMID: 41056514
Borgers JSW, Johnson DB, Livingstone E, Schadendorf D, Buchbinder EI, Haydu LE, Gohil L, Robinson WA, Mehmi I, Hamid O, Ferreira M, Salama AKS, Dimitriou F, Carlino MS, Long GV, Ascierto PA, Simeone E, Najjar YG, Hospers GAP, Choi J, Chandra S, Wayne JD, García CIR, Xu W, Lebbé C, Da-Meda L, Atkinson V, Mckean M, Forschner A, Asare EA, Daletzakis A, Taylor JS, Amant F, Tsai KK, Eroglu Z, Haanen JBAG, Glitza de Oliva IC. Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study. EClinicalMedicine. 2025. PMID: 41127564
Johanna Balas, Lauren Bowling, Nonna Shakhnazaryan, Rahul Raj Aggarwal, Hala Borno, Julian C. Hong, Franklin W. Huang, Barry Tong, Daniel H. Kwon. Evaluating an artificial intelligence (AI) communication platform for racial biases in information quality about prostate cancer (PCa) germline testing. JCO oncology practice. 2025. PMID:
Schram AM, Naqash AR, Haura EB, Riess JW, Ulahannan SV, Ou SI, Munster PN, Cheng ML, Gustafson WC, Bitman B, Friedman R, Penn R, Kar S, Seshadri V, Wang Z, Tao L, Yang YC, Singh M, Burris HA, Meyerowitz JG. The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025. PMID: 41056387
Foster L, Anderson LD, Chung A, Chaulagain CP, Pettijohn E, Cowan AJ, Costello C, Larson S, Sborov DW, Shain KH, Silbermann R, Voorhees P, Krevvata M, Pei H, Patel S, Khare V, Cortoos A, Carson R, Lin TS, Badros A. Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses. Blood cancer journal. 2025. PMID: 41053004
Blaisdell A, Bachl S, Sandoval LR, Ching C, Bowman CJ, Kale N, Prabandham M, Diolaiti M, Havig C, Advincula R, Lenci N, Li Z, Yamashita E, Wang CH, Zhang S, Liu Q, Achacoso P, Stibor D, Øynebråten I, Seo J, Ashworth A, Marson A, Ye CJ, Malynn BA, Eyquem J, Carnevale J, Ma A. Base-editing a single missense mutation in A20 enhances CAR-T cell efficacy. bioRxiv : the preprint server for biology. 2025. PMID: 41446213
Parikh RB, Iasonos A, Ko A, Warner J, Miller K, Friedberg JW. Bringing Trustworthy Artificial Intelligence to the Clinical Forefront at JCO: A Guide for Studies Testing Artificial Intelligence Models. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025. PMID: 41037760
Yamamoto K, Bando H, Misumi T, Nishikawa T, Wakabayashi M, Yamazaki K, Maehara Y, Oki E, Saltz LB, Douillard JY, Punt CJ, Koopman M, Van Cutsem E, Bokemeyer C, Venook AP, Heinemann V, Cremolini C, Randolph Hecht J, Schmoll HJ, Nakayama G, Lenz HJ, Andre T, Shi Q, de Gramont A, Shitara K, Yoshino T. Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study. European journal of cancer (Oxford, England : 1990). 2025. PMID: 41056789
Christopher N. Johns, Hala T. Borno, Samuel L. Washington, Wesley Robinson, Miriam Perales, Rahul R. Aggarwal, Rohit Bose, Jonathan Chou, Ivan de Kouchkovsky, Arpita Desai, Kelly N. Fitzgerald, Terence W. Friedlander, Vadim S. Koshkin, Elizabeth Pan, Eric J. Small, Noah S. Younger, Xiaolin Zhu, Franklin W. Huang, Daniel H. Kwon. Development of a Culturally Tailored Educational Tool to Increase Somatic Testing Participation Among Black Men With Metastatic Prostate Cancer. JCO Oncology Advances. 2025. PMID: